Skip to content
Key Proteo, Inc. logo — Changing the Clinical Course of Treatable Rare Genetic Disor...

Key Proteo, Inc.

Changing the Clinical Course of Treatable Rare Genetic Disorders

Founded 2019 United States Seattle, United States 4 employees Seed Total: $3.03M Health Care, Medical Devices

General Information

Company Name Key Proteo, Inc.
Founded Year 2019
Location United States Seattle, United States
Employees 4
Industries Health Care, Medical Devices
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Service Fee, Subscription, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Key Proteo, Inc.. To contact Key Proteo, Inc., visit keyproteo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Key Proteo, Inc. compare?

A PDF of Key Proteo, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Key Proteo, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Key Proteo, Inc.

Key Proteo, Inc., founded in 2019, is making strides in the Health Care and Medical Devices industries. Based in the United States, the company is committed to "Changing the Clinical Course of Treatable Rare Genetic Disorders" through cutting-edge proteomic analysis.

Initially focusing on newborns, Key Proteo aims to democratize the early detection of rare but treatable genetic disorders. By identifying extremely low abundance protein biomarkers previously considered undetectable, the company offers a novel approach to newborn screening. Early intervention for such disorders can potentially alter their clinical outcomes, fulfilling the company’s mission to alleviate patient suffering and save lives.

In a recent development, Key Proteo secured a $3.03M Seed Round investment on 16 May 2023, signaling confidence in its potential from the investment community. The capital will likely support the expansion of their screening technologies and mission-driven projects. This company presents a compelling opportunity for investors seeking innovation in genetic disorder diagnostics.

Business keywords: Proteomics, Genetic disorders, Newborn screening, Early detection, Peptide screening, Protein biomarkers, Mass spectrometry, Rare diseases, Medical technology, Healthcare innovation

Services & Products

Screening and Diagnostic Testing
Proteomic-based Screening Platform

Target Customers

Healthcare Providers Geneticists Hospitals Research Institutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $3.03M -
16 May 2023
Seed Round Undisclosed 1
MINT Venture Partners
01 Dec 2021

Key Proteo, Inc. Alternatives & Competitors

View All Alternatives
Key Proteo, Inc. vs
Cyted Health
Cyted Health United Kingdom

Transforming access to digestive health for everyone, everywhere.

Non Equity Assistance
74 employees
AI, Biotechnology
Key Proteo, Inc. vs
Reyedar
Reyedar The Netherlands

Medtech startup that combines eye tracking and A.I. to provide fast, objective, and patient-friendly...

Seed
11 employees
Health Care, Manufacturing
Key Proteo, Inc. vs
Eyenuk, Inc.
Eyenuk, Inc. United States

Global artificial intelligence (AI) medical technology and services company

24 employees
AI, Health Care

FAQ About Key Proteo, Inc.

Changing the Clinical Course of Treatable Rare Genetic Disorders
Key Proteo, Inc. was founded in 2019.
Key Proteo, Inc. is headquartered in Seattle, United States.
Key Proteo, Inc. operates in Health Care and Medical Devices. Its work centres on Proteomics, Genetic disorders, Newborn screening and Early detection. Its customers include Healthcare Providers, Geneticists and Hospitals.
Key Proteo, Inc. has a B2B, SaaS and Platform business model. Its revenue comes from Service Fee, Subscription and Usage Based.
Key Proteo, Inc. has approximately 4 employees.
Key Proteo, Inc. has completed 2 funding rounds, raising a total of $3.03M. The latest funding stage is Seed.
Key Proteo, Inc. offers: Screening and Diagnostic Testing, Proteomic-based Screening Platform.
Top alternatives and competitors to Key Proteo, Inc. include Cyted Health, Reyedar, Eyenuk, Inc., Endiatx, Breath Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Key Proteo, Inc. and Cyted Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Key Proteo, Inc., https://bouncewatch.com/company/key-proteo, updated 21 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout